secwatch.observer — SEC 8-K summary
======================================

Issuer:     NIKA PHARMACEUTICALS, INC (NIKA)
CIK:        0001145604
Form:       8-K
Filed at:   2023-09-18T23:59:59+00:00
Accession:  0001826466-23-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.01, 9.01, 3.02, 3.03, 5.01, 5.06
LLM model:  deepseek-v4-flash:cloud@v2

Nika Pharmaceuticals provides Form 10 info, discloses ownership and auditor change as former shell
--------------------------------------------------------------------------------

- Change of control completed Apr 1, 2022: Dimitar Savov acquired 87% of common stock for $140,000.
- As of Aug 31, 2023, Savov holds 38.04% common stock and 100% preferred stock, controlling 100% voting power.
- Company ceased to be a shell as of Apr 11, 2022; business focus on TNG production and dietary supplements.
- Auditor changed: dismissed Pinnacle Accountancy Group on Aug 18, 2022; engaged BF Borgers CPA PC on Oct 24, 2022.
- Common stock not traded on any exchange; approximately 64 holders of record as of Sept 14, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145604/000182646623000033/0001826466-23-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145604/000182646623000033/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001826466-23-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer